BA vs BCRX · P/E 89, rev $24.56B vs rev $374.7M
The Boeing Company (BA) versus BioCryst Pharmaceuticals Inc (BCRX) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BA revenue for 2026-06-30 was $24.56B. Net income was -$444.0M. Revenue was up 10.5% from 2026-03-31 to 2026-06-30. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
BA currently screens at market cap $177.86B and trailing P/E 89.2. BCRX currently screens at market cap $1.83B.
Not investment advice. Open the BA and BCRX stock pages for the full models.
Not investment advice.